Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

PRF Technologies Ltd.

  • Public · NASDAQ: PRFX
  • 6 employees
$1.4MMarket cap
$17.0KRevenue · FY2025
-$5.0MNet income
6Employees
PRFXNASDAQ
2020IPO

About PRF Technologies Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$17.0K
Net income
-$5.0M
Total assets
$12.0M
Market cap
$1.4M

Source: SEC EDGAR · updated Jun 8, 2026

NASDAQ: PRFX

15-minute delayed · data by Polygon.io

Market cap
$1.4M
Open
Day range
Prev close
Volume
IPO date
Sep 1, 2020

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review PRF Technologies Ltd..

Write a review
Explore

Similar companies

Browse all →